SURG · SurgePays, Inc. · Executive Compensation
$0.15
+0.01 (+3.90%)
At close · Nov 13
Return incl. dividend (before tax)
Play latest call
Q1 2026 earnings call transcript
Going-concern doubt
— flagged Aug 19, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These conditions and events, considered in the aggregate, raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date these consolidated financial statements are issued. Accordingly, management has concluded that its plans do not alleviate the substantial doubt about the Company’s ability to continue as a going concern.”View the 10-Q filed Aug 19, 2026
Market Cap
$7.45M
Shares
52.91M
Volume · Nov 12
3.71M
Avg daily vol (3M)
15.8M
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.
No Compensation Data
No Summary Compensation Table has been imported from this company's proxy statements yet.
Executive changes
| Person | Role | Change | Filed |
|---|---|---|---|
| Chelsea Pullano | Interim Chief Financial Officer | Appointed | 2026-01-14 |
| Richard Schurfeld | member of the Board of Directors | Resigned | 2026-01-07 |
| Jeremy Gies | President | Appointed | 2024-01-12 |
| Richard Schurfeld | member of the Board | Appointed | 2022-12-23 |
| Laurie Weisberg | member of the Board | Appointed | 2022-12-23 |
| Jay Jones | Director | Resigned | 2022-12-23 |
Leadership
- Kevin Brian Cox CEO
- Chelsea Pullano CFO
- David May Board Member
- David N. Keys Board Member
- Laurie Weisberg Board Member
- Richard Schurfeld Board Member
Key facts
CIK
1392694
CUSIP
86882L204
13F (30d)
19 filings
18 filers
Visit website
Investor relations